Literature DB >> 19804496

Childhood vitiligo: a long-term study of localized vitiligo treated by noncultured cellular grafting.

Sanjeev V Mulekar1, Abdullah Al Eisa, Mohamed Bilal Delvi, Ahmed Al Issa, Abdul Hamid Al Saeed.   

Abstract

Segmental type was the second most commonly reported in childhood vitiligo. No significant difference has been reported in the prevalence of childhood and adult focal vitiligo. However, the prevalence of segmental vitiligo has been found to be higher in children compared with that in adults. All available medical and phototherapy options are limited by adverse effects or unsatisfactory efficacy. Surgical techniques may be preferred but are not recommended for children as they are time consuming and associated with technical difficulties. In a retrospective review, 25 children aged 4 to 16 years were treated by autologous, noncultured cellular grafting performed under sedation supplemented with local anaesthesia and were followed up for a period of 9 to 54 months postgrafting. Repigmentation was graded as excellent with 95% to 100% pigmentation, good with 65% to 94%, fair with 25% to 64%, and poor with 0% to 24% of the treated area. In the segmental group, eight (62%) showed excellent, two (15%) good, one (8%) fair, and two (15%) poor pigmentation, which was retained until the end of the respective follow-up period. In the focal group, nine (75%) showed excellent, and one (8%) each showed good, fair, and poor pigmentation, which was retained until the end of the respective follow-up period. Noncultured cellular grafting may be considered to treat childhood localized vitiligo.

Entities:  

Mesh:

Year:  2009        PMID: 19804496     DOI: 10.1111/j.1525-1470.2009.00978.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  6 in total

1.  A Review of Non-cultured Epidermal Cellular Grafting in Vitiligo.

Authors:  Nanja van Geel; Boon Kee Goh; Elien Wallaeys; Stefanie De Keyser; Jo Lambert
Journal:  J Cutan Aesthet Surg       Date:  2011-01

Review 2.  Autologous non-cultured melanocyte-keratinocyte transplantation in the treatment of vitiligo: patient selection and perspectives.

Authors:  Dalia Bassiouny; Samia Esmat
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-10-26

3.  Inhibition of Fam114A1 protects melanocytes from apoptosis through higher RACK1 expression.

Authors:  Miaoni Zhou; Fuquan Lin; Xingang Wu; Zhuyi Ping; Wen Xu; Rong Jin; Aie Xu
Journal:  Aging (Albany NY)       Date:  2021-11-27       Impact factor: 5.682

Review 4.  Advances in vitiligo: Update on therapeutic targets.

Authors:  Yifei Feng; Yan Lu
Journal:  Front Immunol       Date:  2022-08-31       Impact factor: 8.786

5.  Childhood vitiligo: treatment paradigms.

Authors:  Amrinder Jit Kanwar; M Sendhil Kumaran
Journal:  Indian J Dermatol       Date:  2012-11       Impact factor: 1.494

Review 6.  Immunological Parameters Associated With Vitiligo Treatments: A Literature Review Based on Clinical Studies.

Authors:  Ana Cláudia Guimarães Abreu; Gabriela Guy Duarte; Juliana Yasmin Pains Miranda; Daniel Gontijo Ramos; Camila Gontijo Ramos; Mariana Gontijo Ramos
Journal:  Autoimmune Dis       Date:  2015-09-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.